Last updated 16 days ago

A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

160 patients around the world
Available in Peru, Mexico, United States, Argentina, Brazil
Hoffmann-La Roche
16Research sites
160Patients around the world
This study is for people with
Breast Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Provincial del Centenario - Rosario, Santa Fe
Recruiting
Urquiza 3101, Rosario, Santa Fe
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Dorrego 269, La Rioja
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
Recruiting
Av. Galvan 4102, CABA, Buenos Aires
Sanatorio Parque - Rosario
Recruiting
Boulevard Oroño 860, Rosario, Santa Fe
Centro Oncológico Korben
Recruiting
Cdad. de La Paz 353, C1426 CABA, Argentina
Fundación CENIT para la Investigación en Neurociencias
Recruiting
Juncal 2222, C1125 CABA, Argentina
Clínica de Pesquisas e Centro de Estudos em Oncologia Ginecológica e Mamária
Recruiting
733 Avenida Brigadeiro Luís Antônio São Paulo, SP 01317-001
INSCER - Instituto do Cérebro da PUC-RS
Recruiting
Av. Ipiranga, 6690, 4o Andar, Centro de Pesquisa Clínica do HSLPUCRS - Jardim Botânico – Porto Alegre/RS - 90610-000
Hospital Araújo Jorge
Recruiting
R. 239, 206 - Setor Leste Universitário, Goiânia - GO, 74605-070
Hospital de Câncer de Pernambuco
Recruiting
Av. Cruz Cabugá, 1597 - Santo Amaro, Recife - PE, 50040-000
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy